Home>Bulk Products>7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD759766[2260710-34-5]7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine*

Specific Information

Purity : 95% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD759766 Synonyms : 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine
CAS No. : 2260710-34-5 MDL NO : MFCD30530481
Formule : C12H16BN3O2 InChI Key : N/A
M.W : 245.09 Pubchem ID : 127263902
Boiling Point :

Safety

Signal Word : Warning Class : N/A
Precautionary Statements : P261-P305+P351+P338 UN# : N/A
Hazard Statements : H302-H315-H319-H335 Packing Group : N/A
GHS Pictogram:

R&D Center